Page last updated: 2024-11-13

10-hydroxywarfarin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

10-hydroxywarfarin is a **metabolite** of warfarin, a common anticoagulant medication.

Here's why it's important for research:

* **Pharmacokinetic Studies:** Understanding the metabolism of warfarin is crucial for determining its dosage and effectiveness. 10-hydroxywarfarin is the major active metabolite of warfarin, meaning it contributes significantly to the drug's overall anticoagulant effect. Researchers study the formation, elimination, and interaction of 10-hydroxywarfarin with other drugs to optimize warfarin therapy.
* **Pharmacogenetic Research:** Individual variability in how people metabolize warfarin is a major factor in the drug's effectiveness and risk of bleeding complications. Research on 10-hydroxywarfarin helps identify genetic variations that influence its production and clearance. This information can be used to personalize warfarin dosing and reduce the risk of adverse events.
* **Drug Interactions:** 10-hydroxywarfarin can interact with other medications, potentially altering its effectiveness or causing adverse effects. Researchers study these interactions to identify drugs that may need to be adjusted or avoided in patients taking warfarin.
* **Drug Development:** Research on 10-hydroxywarfarin helps inform the development of new anticoagulant drugs. By studying the mechanism of action and metabolism of warfarin, researchers can develop safer and more effective anticoagulants.

**In summary, 10-hydroxywarfarin is crucial for understanding the pharmacokinetics, pharmacogenetics, and drug interactions of warfarin. This research has significant implications for optimizing warfarin therapy and developing new anticoagulant drugs.**

10-hydroxywarfarin: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID54692492
CHEMBL ID3544634
CHEBI ID190806
MeSH IDM0180631

Synonyms (21)

Synonym
2h-1-benzopyran-2-one, 4-hydroxy-3-(2-hydroxy-3-oxo-1-phenylbutyl)-
NCGC00165935-01
4-hydroxy-3-(2-hydroxy-3-oxo-1-phenylbutyl)-2h-1-benzopyran-2-one
10-hydroxywarfarin
83219-99-2
4-hydroxy-3-(2-hydroxy-3-oxo-1-phenylbutyl)chromen-2-one
CHEBI:190806
4-hydroxy-3-(2-hydroxy-3-oxo-1-phenylbutyl)-2h-chromen-2-one
2-hydroxy-3-(2-hydroxy-3-oxo-1-phenyl-butyl)chromen-4-one
A840536
FT-0641897
4-hydroxy-3-(2-hydroxy-3-oxo-1-phenylbutyl)-2h-1-benzopryan-2-one
CHEMBL3544634
BPZSPAZBZFZZBN-UHFFFAOYSA-N
DTXSID201003207
2-hydroxy-3-(2-hydroxy-3-oxo-1-phenylbutyl)-4h-1-benzopyran-4-one
10-hydroxy warfarin
10-hydroxy warfarin (mixture of diastereomers)
PD151329
AKOS040755453
2-hydroxy-3-(2-hydroxy-3-oxo-1-phenylbutyl)-1-benzopyran-4-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
hydroxycoumarinAny coumarin carrying at least one hydroxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (8.33)18.2507
2000's5 (41.67)29.6817
2010's6 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.52 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index5.15 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (8.33%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]